A detailed history of Orion Investment CO transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Orion Investment CO holds 25,220 shares of BMY stock, worth $1.45 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares
25,220
Previous 25,405 0.73%
Holding current value
$1.45 Million
Previous $1.06 Billion 23.68%
% of portfolio
0.51%
Previous 0.42%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$39.66 - $51.75 $7,337 - $9,573
-185 Reduced 0.73%
25,220 $1.3 Billion
Q2 2024

Aug 14, 2024

BUY
$40.25 - $52.99 $1.02 Million - $1.35 Million
25,405 New
25,405 $1.06 Billion

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Orion Investment CO Portfolio

Follow Orion Investment CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orion Investment CO, based on Form 13F filings with the SEC.

News

Stay updated on Orion Investment CO with notifications on news.